Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions
- PMID: 19057248
- DOI: 10.1097/BSD.0b013e31815ea897
Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions
Abstract
Study design: All patients of spinal interbody fusion using polyetheretherketone (PEEK) cages and recombinant human bone morphogenetic protein (rhBMP)-2 performed over a 16-month period were reviewed.
Objective: To determine the suitability of PEEK cages when used in conjunction with rhBMP-2 in interbody spinal fusion.
Summary of background data: Bone morphogenetic proteins are increasingly being used in spinal fusion to promote osteogenesis. PEEK is a semicrystalline aromatic polymer that is used as a structural spacer to maintain the disc and foraminal height. Their use has led to increased and predictable rates of fusion. However, not many reports of the adverse effects of their use are available.
Methods: Fifty-nine consecutive patients of interbody spinal fusion in the cervical or lumbar spine using a PEEK cage and rhBMP-2 were followed for an average of 26 months after surgery. A clinical examination and a record of Oswestry Disability Index, Visual Analog Scale for pain, and a pain diagram were performed preoperatively and at every follow-up visit. All patients had plain radiographs carried out to assess fusion. Ten patients of lumbar spine fusion were additionally evaluated with a computed tomography scan.
Results: All cases demonstrated an appreciable amount of new bone formation by 6 to 9 months in the cervical spine and by 9 to 12 months in the lumbar spine. End plate resorption was visible radiologically in all cervical spine fusions and majority of lumbar fusions. Cage migration was observed to occur maximally in patients with transforaminal lumbar interbody fusion and posterior lumbar interbody fusion. Disc space subsidence was seen in both cervical and lumbar arthrodesis with the latter showing a lesser incidence, but with a greater degree of collapse.
Conclusions: PEEK cages and rhBMP-2 when used in spinal fusion give consistently good fusion rates. However, the early role of BMP in the resorptive phase may cause loosening, cage migration, and subsidence.
Comment in
-
End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions.J Spinal Disord Tech. 2009 Jun;22(4):309; author reply 310. doi: 10.1097/BSD.0b013e3181a5abfa. J Spinal Disord Tech. 2009. PMID: 19494752 No abstract available.
Similar articles
-
End plates resorptions after the applications of rhBMP-2 for interbody spinal fusions.J Spinal Disord Tech. 2009 Jun;22(4):309; author reply 310. doi: 10.1097/BSD.0b013e3181a5abfa. J Spinal Disord Tech. 2009. PMID: 19494752 No abstract available.
-
Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.Spine J. 2009 Dec;9(12):959-66. doi: 10.1016/j.spinee.2009.05.008. Epub 2009 Jul 1. Spine J. 2009. PMID: 19574105
-
Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.Spine J. 2007 May-Jun;7(3):301-7. doi: 10.1016/j.spinee.2006.10.015. Epub 2007 Jan 2. Spine J. 2007. PMID: 17482113 Clinical Trial.
-
Interbody cage devices.Spine (Phila Pa 1976). 2003 Aug 1;28(15 Suppl):S2-7. doi: 10.1097/01.BRS.0000076841.93570.78. Spine (Phila Pa 1976). 2003. PMID: 12897467 Review.
-
Bone morphogenetic proteins for spinal fusion.Spine J. 2005 Nov-Dec;5(6 Suppl):240S-249S. doi: 10.1016/j.spinee.2005.02.014. Spine J. 2005. PMID: 16291119 Review.
Cited by
-
BMP2-induced inflammation can be suppressed by the osteoinductive growth factor NELL-1.Tissue Eng Part A. 2013 Nov;19(21-22):2390-401. doi: 10.1089/ten.TEA.2012.0519. Epub 2013 Jul 17. Tissue Eng Part A. 2013. PMID: 23758588 Free PMC article.
-
Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells.Biomacromolecules. 2015 Sep 14;16(9):2757-65. doi: 10.1021/acs.biomac.5b00694. Epub 2015 Aug 17. Biomacromolecules. 2015. PMID: 26259127 Free PMC article.
-
Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB.J Biol Chem. 2009 Dec 18;284(51):35987-95. doi: 10.1074/jbc.M109.070540. J Biol Chem. 2009. PMID: 19854828 Free PMC article.
-
Cage subsidence in lateral interbody fusion with transpsoas approach: intraoperative endplate injury or late-onset settling.Spine Surg Relat Res. 2017 Nov 27;1(4):203-210. doi: 10.22603/ssrr.1.2017-0004. eCollection 2017. Spine Surg Relat Res. 2017. PMID: 31440635 Free PMC article.
-
Adverse effects of posterior lumbar interbody fusion using rhBMP-2.Eur Spine J. 2009 Jun;18(6):920-3; author reply 924. doi: 10.1007/s00586-009-0959-z. Epub 2009 Apr 8. Eur Spine J. 2009. PMID: 19352727 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials